Medicinal Genomics

NOVEMBER 5, 2019

Another potential headache for farmers is that analytical laboratories must be registered with the DEA in order to perform compliance testing. No existing cannabis labs are registered with the DEA because they handle a schedule 1 substance, which violates federal law. and seize all the testing samples. THC threshold.

THC 81

THC Hemp DEA Banking 81

Medicinal Genomics

FEBRUARY 8, 2023

All the CannMed 23 oral and poster presenters are vetted by our Advisory Board to ensure the content includes novel research that is clearly communicated in a manner that will generate discussion. You will not see presenters who are selling from the podium at CannMed.

Wellness and Beauty 52

Wellness and Beauty Events Topical Safety 52

Cannabis Law Report

OCTOBER 31, 2019

The first crisis point initiated by the Rule is its requirement that Labs “ must be registered by the DEA to conduct chemical analysis of controlled substances (in accordance with 21 CFR 1301.13). ” The USDA helpfully indicates that it will post directions for obtaining a DEA registration. Will that disqualify Labs in those states?

Hemp 45

Hemp DEA Concentrates THC 45

NewsMunchies

DECEMBER 22, 2021

As of this writing, cannabis remains a prohibited Schedule 1 drug, defined by the DEA as having “no currently accepted medical use and a high potential for abuse.” . At present, the state allows marijuana use only for medical reasons. The commercialization of cannabis is here but federal legalization has not yet come to our shores.

Law 89

Law Marijuana DEA Legalization 89

Canna Law Blog

DECEMBER 4, 2019

Presently, the public comment period ends on December 30, 2019 and it is unclear whether the comment period will be extended. Most of us in the hemp industry are well-aware of the major issues in the interim rules: 15-day pre-harvest testing requirements, total THC, DEA laboratories, and crop insurance to name a few. 3% Total THC.

Hemp 69

Hemp DEA CBD THC 69

Cannabis Law Report

AUGUST 18, 2022

The firm’s deep expertise in pharmaceutical sciences, FDA regulatory compliance and pharmaceutical product liability litigation and risk management enables it to address complex legal hurdles faced by stakeholders seeking to research, develop, invest in and bring-to-market psychedelic therapies. However, change appears imminent.

Therapy 52

Therapy Research and Development Pharmaceutical Treatment 52

SpeedWeed

AUGUST 7, 2021

Depending on the allegations, companies must also stay attentive to federal criminal exposure if information is shared with the Drug Enforcement Agency (DEA). The best protective measure a company can take is to conduct its own internal investigation or, at a minimum, a compliance review. The Legal Gray Area of the Initial Grow.

Seed-To-Sale 52

Seed-To-Sale Compliance Compliance Policy 52

SpeedWeed

AUGUST 7, 2021

Depending on the allegations, companies must also stay attentive to federal criminal exposure if information is shared with the Drug Enforcement Agency (DEA). The best protective measure a company can take is to conduct its own internal investigation or, at a minimum, a compliance review. The Legal Gray Area of the Initial Grow.

Law 52

Law Seed-To-Sale Compliance Compliance 52

SpeedWeed

AUGUST 7, 2021

Depending on the allegations, companies must also stay attentive to federal criminal exposure if information is shared with the Drug Enforcement Agency (DEA). The best protective measure a company can take is to conduct its own internal investigation or, at a minimum, a compliance review. The Legal Gray Area of the Initial Grow.

Business 52

Business Seed-To-Sale Compliance Compliance 52

SpeedWeed

AUGUST 6, 2021

Depending on the allegations, companies must also stay attentive to federal criminal exposure if information is shared with the Drug Enforcement Agency (DEA). The best protective measure a company can take is to conduct its own internal investigation or, at a minimum, a compliance review. The Legal Gray Area of the Initial Grow.

Seed-To-Sale 52

Seed-To-Sale Compliance Compliance Policy 52

Canna Law Blog

JANUARY 17, 2020

percent delta-9 tetrahydrocannabinol or opportunities for remediation or alternative uses; the feasibility of producer compliance with sampling timetables; the feasibility of producer compliance with reporting requirements; and. It was presented with bipartisan support but the legislative process can be unpredictable.

Hemp 97

Hemp CBD Food Cannabinoids 97

SpeedWeed

AUGUST 5, 2021

Depending on the allegations, companies must also stay attentive to federal criminal exposure if information is shared with the Drug Enforcement Agency (DEA). The best protective measure a company can take is to conduct its own internal investigation or, at a minimum, a compliance review. The Legal Gray Area of the Initial Grow.

Environment 52

Environment Seed-To-Sale Compliance Compliance 52

Cannabis Law Report

APRIL 14, 2022

Cannabis businesses that are ill-prepared for these regulatory requirements risk facing litigation, enforcement actions, fines or penalties, and negative publicity, while those taking a proactive approach to compliance may find opportunities to mitigate and even monetize those risks.

Environment 52

Environment Agriculture Compliance Compliance 52

Cannabis Law Report

MAY 31, 2022

The Drug Enforcement Agency (DEA) currently has guidance published for those interested in petitioning for a religious exemption to the CSA. For obvious reasons, religious exemptions from the CSA do not present compelling opportunities for entrepreneurs. 2022 Active FDA Clinical Trials and State-Regulated Systems.

Clinical Trials 52

Clinical Trials Legalization Therapy Decriminalization 52

Canna Law Blog

FEBRUARY 2, 2020

In light of these legislative changes, we are presenting a 50-state series analyzing how each jurisdiction treats hemp-derived cannabidiol (“Hemp CBD”). The Commission believes this “narrow timeframe” is an “unnecessary obstacle for compliance.” Today we turn to North Carolina.

Hemp 102

Hemp CBD Agriculture Cultivation 102

Cannabis Law Report

APRIL 24, 2019

The second path would be the administrative action by the Drug Enforcement Agency [“DEA”] and its Diversion Control Division. Will the mandate for the DEA be changed to oversee another special agricultural legal crop or a medicine ? The first and more conclusive would be through Congress legislation signed by the President.

Legalization 58

Legalization Collective DEA Banking 58

Cannabis Law Report

FEBRUARY 17, 2020

It has been less than eight years since the DEA, the Criminal Investigation Division of IRS, and the Office of the U.S. It is the management of taxes that presents the challenge for a cannabis business not the rate of tax or the unfairness of its imposition. The announcement would have been made whether or not it was true.

Collective 59

Collective Business Cultivation Compliance 59

Cannabis Law Report

FEBRUARY 23, 2019

The compliance is through the roof; we have binders that run to three-and-a-half feet in length across the floor with compliance information. Mr O’Brien said there are fewer than 700 legal cultivation sites in operation in the area, but he estimates that roughly the same number are operating without permits at present.

Cultivation 40

Cultivation Patients Compliance Compliance 40

Cannabis Law Report

AUGUST 6, 2021

The first quarter fiscal 2022 and first quarter fiscal 2021 financial results presented in this press release have been prepared in accordance with U.S. GAAP and may not be comparable to similar measures presented by other companies. GAAP and may not be comparable to similar measures presented by other companies.

Vaping 105

Vaping Research and Development Data Business 105

Cannabis Law Report

JUNE 1, 2021

The fourth quarter fiscal 2021, fourth quarter fiscal 2020, fiscal year 2021 and fiscal year 2020 financial results presented in this press release have been prepared in accordance with U.S. GAAP and may not be comparable to similar measures presented by other companies. Webcast and Conference Call Information. Non-GAAP Measures.

Data 95

Data Vaping Supply Chain Business 95

Cannabis Law Report

JULY 30, 2019

Each patient and physician boldly proceed to maneuver Florida’s present physician and patient compliance system together, not to mention the issues: state vs. federal legality conflicts. Cannabis is not a “gateway” drug, according to the ASA and the DEA’s own statements cited in the August 2016 U.S.

Marijuana 45

Marijuana Patients Research and Development Programs 45

Cannabis Law Report

MAY 1, 2019

9 Even under the Obama-era policy, Weedmaps might still be exposing itself to federal prosecution because it is not “demonstrably in compliance with [California’s] strong and effective. Even then, publishers should require that any cannabis-business certify its compliance with state and local laws. Conclusion.

Legalization 45

Legalization Business Law Cannabis 45

Cannabis Law Report

NOVEMBER 2, 2021

Five of them used an age verification form , which is in compliance with the FDA age requirements and state laws, where the customer has to upload a photo of a government ID, and the other required a signature on delivery of the package. The second argument is based on a DEA interim final rule on the topic of synthetic THC.

THC 96

THC CBD Legalization Vaping 96

Cannabis Law Report

MAY 17, 2019

Seq (1970) and Drug Enforcement Administration’s (“DEA”) clutches, 2019 hemp production and sales exploded. Because it can’t be sold between the states and is presently incapable of entering the stream of interstate commerce, the Marijuana industry has been spared the FDA’s scrutiny. Budgeted at $6.1

Food 10

Food DEA Hemp CBD 10

Cannabis Law Report

SEPTEMBER 23, 2019

Due to the Schedule I classification by the Drug Enforcement Agency (DEA), researchers seeking to investigate health effects associated with cannabis must follow a regimented application process. The required processes and procedures present a serious burden, dissuading researchers from pursuing cannabis-related projects.

Cannabinoids 40

Cannabinoids Marijuana Research and Development Access 40

Cannabis Law Report

MARCH 25, 2019

At the present time, state medical and recreational legalization have no impact on federal drug control laws. The DEA has made previous requests–in 2001 and 2006–to the FDA for an evaluation of marijuana. But DEA regulators determined after both of those reviews that marijuana should remain a Schedule I substance.

Banking 45

Banking Law Marijuana State Laws 45